Literature DB >> 25661331

CRKL overexpression suppresses in vitro proliferation, invasion and migration of murine hepatocarcinoma Hca-P cells.

Qiuyue Lin1, Ming-Zhong Sun2, Chunmei Guo2, Ji Shi3, Xin Chen4, Shuqing Liu5.   

Abstract

The signal adaptor CRK family protein play important roles in cancer cell progression, proliferation, migration and invasion. Previously, we showed that CRK was involved in lymphatic metastatic potential of murine hepatocarcinoma cells. In current work, as a member of CRK family, chicken tumour virus number 10 regulator of kinase-like protein (CRKL) was revealed to be associated with malignant behaviors of Hca-P, a murine HCC cell with lymph node metastatic (LNM) rate of ∼25%. CRKL overexpression in Hca-P by a constructed eukaryotic expression vector of pcDNA3.1/V5-HisB-CRKL significantly ameliorated its malignant biological properties. CCK-8 and soft agar colony formation assays indicated CRKL overexpression significantly inhibits the cell proliferation and colony formation abilities of Hca-P. Additionally, transwell assays indicated that the Hca-P cell migration and invasion capacities were apparently reduced following CRKL overexpression. As Hca-P is an ideal hepatocarcinoma cell model with low (initial) LNM potential, CRKL is shown to act as a potential suppressor and to provide new insight for both the malignant behaviors of hepatocarcinoma cells and lymphatic metastasis mechanism of hepatocarcinoma.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CRKL; Hepatocarcinoma; Invasion; Migration; Proliferation

Mesh:

Substances:

Year:  2014        PMID: 25661331     DOI: 10.1016/j.biopha.2014.10.025

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  CRKII overexpression promotes the in vitro proliferation, migration and invasion potential of murine hepatocarcinoma Hca-P cells.

Authors:  Zanmei Zhou; Xiuyan Sun; Chunmei Guo; Ming-Zhong Sun; Shuqing Liu
Journal:  Oncol Lett       Date:  2019-03-27       Impact factor: 2.967

2.  ANXA11 regulates the tumorigenesis, lymph node metastasis and 5-fluorouracil sensitivity of murine hepatocarcinoma Hca-P cells by targeting c-Jun.

Authors:  Shuqing Liu; Chunmei Guo; Jiasheng Wang; Bo Wang; Houbao Qi; Ming-Zhong Sun
Journal:  Oncotarget       Date:  2016-03-29

3.  miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.

Authors:  Chunmei Guo; Dongting Zhao; Qiuling Zhang; Shuqing Liu; Ming-Zhong Sun
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

4.  Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways.

Authors:  Xujuan Sun; Shuqing Liu; Jinxia Wang; Bin Wei; Chunmei Guo; Chen Chen; Ming-Zhong Sun
Journal:  Cell Death Dis       Date:  2018-05-25       Impact factor: 8.469

5.  A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.

Authors:  Chunmei Guo; Chao Gao; Dongting Zhao; Jiahui Li; Jinxia Wang; Xujuan Sun; Qinlong Liu; Lihong Hao; Frederick T Greenaway; Yuxiang Tian; Shuqing Liu; Ming-Zhong Sun
Journal:  J Exp Clin Cancer Res       Date:  2020-04-23

6.  CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt.

Authors:  Chunmei Guo; Chao Gao; Xinxin Lv; Dongting Zhao; Frederick T Greenaway; Lihong Hao; Yuxiang Tian; Shuqing Liu; Ming-Zhong Sun
Journal:  J Cell Mol Med       Date:  2021-02-01       Impact factor: 5.310

7.  MiR-378 and MiR-1827 Regulate Tumor Invasion, Migration and Angiogenesis in Human Lung Adenocarcinoma by Targeting RBX1 and CRKL, Respectively.

Authors:  Chai San Ho; Suzita Mohd Noor; Noor Hasima Nagoor
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

8.  Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method.

Authors:  Cheng-Wei Li; Ping-Yao Chang; Bor-Sen Chen
Journal:  Oncotarget       Date:  2016-11-29

Review 9.  Crk and CrkL as Therapeutic Targets for Cancer Treatment.

Authors:  Taeju Park
Journal:  Cells       Date:  2021-03-27       Impact factor: 6.600

10.  Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.

Authors:  Jiang Yu; Wen-Xu Chen; Wen-Jing Xie; Rong-Wei Chen; Dan-Qi Lin; Wei-Wei You; Wei-Lin Ye; Hong-Qin Zhang; Dong-Hong Lin; Jian-Ping Xu
Journal:  J Clin Lab Anal       Date:  2021-06-11       Impact factor: 2.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.